Skip to main content
. 2020 Mar 6;10:4183. doi: 10.1038/s41598-020-60991-7

Table 4.

Incidence rates of URTI in the total study population.

Incidence Rate (per 100 person days) p value
Active Placebo
URTI Symptoms 1.30 2.16
   IRR (95% CI) 0.60 (0.52, 0.70) <0.0001
Individual URTI symptoms
 Sneezing 0.71 1.31
   IRR (95% CI) 0.54 (0.44, 0.66) <0.0001
 Cough 0.38 0.57
   IRR (95% CI) 0.67 (0.50, 0.90) 0.0073
 Runny nose 0.46 0.52
   IRR (95% CI) 0.89 (0.67, 1.18) 0.4268
 Blocked nose 0.46 0.64
   IRR (95% CI) 0.72 (0.55, 0.95) 0.0181
 Sore Throat 0.25 0.31
   IRR (95% CI) 0.80 (0.55, 1.17) 0.2512
Other symptoms
 Headache 1.08 1.58
   IRR (95% CI) 0.68 (0.58, 0.81) <0.0001
 Earache 0.08 0.17
   IRR (95% CI) 0.48 (0.27, 0.88) 0.0173
 Muscle pain 0.28 0.42
   IRR (95% CI) 0.67 (0.48, 0.95) 0.0225
 Chest wheeze 0.09 0.15
   IRR (95% CI) 0.62 (0.34, 1.12) 0.1112
 Itchy eyes 0.19 0.23
   IRR (95% CI) 0.80 (0.52, 1.24) 0.3218
Antibiotic usage 0.08 0.08
   IRR (95% CI) 0.94 (0.46, 1.89) 0.8552

Data is presented as incidence rate or incidence rate ratios (IRR) of 110 participants per group with 95% CIs and p values were calculated using a GLM with Poisson distribution and log link function. CI, confidence interval.